Almac Extends Site-Specific PEGylation Technology to Single Domain Antibodies

News   Apr 29, 2010

 
Almac Extends Site-Specific PEGylation Technology to Single Domain Antibodies
 
 
 

RELATED ARTICLES

FoxO Proteins Implicated in Arthritis Age Risk

News

A study examining osteoarthritis has shown that as joints age, levels of FoxO decrease, causing pain and inflammation.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

Radioprotective Drugs Assessed Using Human Gut Organ-on-a-Chip

News

Researchers have published a study using an organ-on-a-chip (Organ Chip) model of the human gut that reveals the intestinal blood vessel cells may play an important part in radiation-induced intestinal injury, and it confirms that a potential radioprotective drug, dimethyloxaloylglycine (DMOG), suppresses the intestine’s responses to radiation injury.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE